Jazz Pharmaceuticals Plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jazz Pharmaceuticals Plc with three other
pharmaceutical manufacturers in Europe:
Krka DD Novo Mesto
sales of 1.16 billion Euro [US$1.24 billion]
of which 64%
was European Union),
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
(365.22 billion Hungarian Forints [US$1.26 billion]
of which 82%
was Pharmaceutical Manufacturing and Sale), and
Croda International Plc
based in the United Kingdom
(£1.08 billion [US$1.33 billion]
of which 35%
was Personal Care).
During the year ended December of 2015, sales at
Jazz Pharmaceuticals Plc were 1.20 billion Euro (US$1.28 billion).
increase of 35.2%
versus 2014, when the company's sales were 888.27 million Euro.
This was the fifth consecutive year of sales increases at Jazz Pharmaceuticals Plc
(and since 2010, sales have increased a total of 812%).